Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional Results available

Study of V117957 in Overactive Bladder Syndrome

ClinicalTrials.gov ID: NCT06024642

Public ClinicalTrials.gov record NCT06024642. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 3:41 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Multicenter, Randomized, Double-blind Placebo-controlled, Crossover Study to Investigate Effects of V117957 in Female Subjects With Overactive Bladder Syndrome

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the safety, tolerability and efficacy of V117957 in subjects with overactive bladder syndrome, compared to placebo.

Study identification

NCT ID
NCT06024642
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
Imbrium Therapeutics
Industry
Enrollment
51 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2022 (Actual)
Primary completion
May 21, 2024 (Actual)
Completion
May 21, 2024 (Actual)
Last update posted
Jun 26, 2025

2022 – 2024

United States locations

U.S. sites
12
U.S. states
8
U.S. cities
12
Facility City State ZIP Site status
Arizona Urology Specialists, PLLC Tucson Arizona 85715 —
Hope Clinical Research, LLC Canoga Park California 91303 —
ARK Clinical Research Long Beach California 90815 —
Urology Group of Southern California Los Angeles California 90017 —
Providea Health Partners, LLC Evergreen Park Illinois 60805 —
DelRicht Research New Orleans Louisiana 70115 —
Ochsner LSU Health Shreveport - Regional Urology Shreveport Louisiana 71106 —
Boston Clinical Trials Boston Massachusetts 02131 —
Bay State Clinical Trials, Inc. Watertown Massachusetts 02472 —
AccuMed Research Associates Garden City New York 11530 —
Unified Women's Clinical Research-Lyndhurst Winston-Salem North Carolina 27103 —
The Clinical Trial Center, LLC Jenkintown Pennsylvania 19046 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06024642, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 26, 2025 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06024642 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →